drugset / Trial / NCT03404466
To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of Hypidone Hydrochloride tablets in treatment of patients with major depressive disorder (MDD) by evaluating the change of MADRS total score from baseline to week 6.
Timeline
- Start
- 2018-02-24
- Primary completion
- 2018-07-10
- Completion
- 2018-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypidone Hydrochloride | Unknown | 10 mg | Oral |
| Subject | Hypidone Hydrochloride | Unknown | 20 mg | Oral |